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Background: One of the principal mechanisms by which
G-protein-coupled receptors evoke cellular responses is
through the activation of phospholipase C (PLC) and the
subsequent release of Ca2+ from intracellular stores.
Receptors that couple to pertussis toxin (PTX)-insensitive
G proteins typically evoke large increases in PLC activity
and intracellular Ca2 + release. In contrast, receptors that
use only PTX-sensitive G proteins usually generate weak
PLC-dependent responses, but efficiently regulate a sec-
ond effector enzyme, adenylyl cyclase. For example, in
many cell types, agonist binding by the m4 muscarinic
acetylcholine receptor (m4 receptor) results in a strong
inhibition of adenylyl cyclase and very little stimulation of
PLC activity or release of intracellular Ca2+ . We have
investigated whether the weak, PTX-sensitive stimulation
of PLC activity by the m4 receptor can play a significant
role in the generation of cellular responses.
Results: We report here that PTX-sensitive Ca2+ release
mediated by the m4 receptor in transfected Chinese ham-
ster ovary cells is greatly enhanced when endogenous puri-
nergic receptors simultaneously activate a PTX-insensitive
signaling pathway. Furthermore, m4-receptor-induced
transcription of the c-fos gene (a Ca2+-sensitive response)
is similarly potentiated when purinergic receptors are co-
activated. These enhanced m4-receptor-dependent Ca2 +
responses do not require an influx of external Ca2+, and
occur in the absence of detectable purinergic-receptor-
stimulated Ca2+ release; they apparently require the acti-
vation of both PTX-sensitive and PTX-insensitive
G-protein pathways. Measurements of phosphoinositide
hydrolysis indicate that the enhancement of m4-receptor-
mediated Ca2 + signaling by purinergic receptors is due to
a synergistic increase in agonist-stimulated PLC activity.
Conclusions: These studies demonstrate that the
potency of m4-receptor-mediated PLC signaling is highly
dependent upon the presence or absence of other PLC-
activating agonists. The ability of the m4 receptor to evoke
a strong, but conditional, activation of PLC may allow this
type of receptor to participate in a coincidence-detection
system that amplifies simultaneous PLC-activating signals
through a mechanism involving crosstalk between PTX-
sensitive and PTX-insensitive G-protein pathways.
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Background
Calcium ions are crucial intracellular messengers that
modulate a wide variety of cellular functions, including
secretion, muscular contraction, metabolism and gene
transcription [1,2]. These complex processes are mediated,
at least partially, by the direct effects of Ca2+ on biochem-
ical targets, such as kinases, proteases, cytoskeletal proteins
and vesicular proteins, as well as on ion channels. Because
of the potent effects of Ca2+ on cell physiology, the rest-
ing cytosolic Ca2+ concentration ([Ca2+]i) is maintained
at low levels - -20-200 nM [3] - by a variety of pumps
and exchange proteins located on the plasma membrane
and on intracellular organelles. Increases in [Ca 2+]i evoked
by neurotransmitter and hormonal receptors are used to
elicit physiological responses in nearly all cell types.
Many different neurotransmitters and hormones elevate
[Ca 2+]i by binding to receptors that interact with
heterotrimeric guanine-nucleotide binding (G) proteins
that in turn stimulate the activity of particular isozymes
of phospholipase C (PLC) [2,4]. Phosphatidylinositol
4,5-bisphosphate (PIP 2) is hydrolyzed by PLC to gener-
ate two second messengers: inositol 1,4,5-trisphosphate
(IP3), which mediates the release of Ca2+ from intra-
cellular stores, and diacylglycerol, a lipid activator of the
serine/threonine-specific kinase family termed protein
kinase C (PKC). The components of the biochemical
pathways leading to PLC stimulation and intracellular
Ca2+ release include perhaps 50 or more receptors, as
well as multiple G proteins and PLC isozymes [4-6].
However, much remains to be learned as regards the
mechanisms by which cells can use multiple receptors,
G proteins and PLC isozymes to generate particular
Ca 2+-release signals and other PLC-dependent responses.
At least two distinct pathways link G-protein-coupled
receptors to PLC stimulation and intracellular Ca2+
release within an individual cell [3,7]. The G proteins in
these pathways can be distinguished by their sensitivity to
pertussis toxin (PTX), a bacterially-derived toxin that
catalyzes the mono-ADP-ribosylation of certain G-pro-
tein ct subunits (G,) and thus uncouples them from their
cognate receptors [8]. Analysis of receptor-stimulated,
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PLC-mediated signaling in primary tissues and cell lines
has demonstrated that many receptors - including B2
bradykinin receptors, 5HTlc serotonin receptors and the
ml, m3 and m5 muscarinic acetylcholine receptor
subtypes -stimulate PLC and Ca2 + release through
PTX-insensitive G proteins [7,9-11]. In contrast, other
receptors - such as o2-adrenergic receptors, 5HTla
serotonin receptors and the m2 and m4 muscarinic
acetylcholine receptor subtypes - activate PLC and
inhibit adenylyl cyclase entirely through PTX-sensitive G
proteins [7,11-14]. In vitro reconstitution and cell-
transfection experiments indicate that PTX-insensitive
PLC activation involves a direct interaction between the
G, /11 class of G-protein ox subunits and the 31 isoform
of PLC. In contrast, the PTX-sensitive pathway appar-
ently requires the binding of G-protein [3y (Gpy) sub-
units, presumably released by G i subunits, to either the
132 or the 3 PLC isoform [4,5,15-20].
The magnitude of a PLC response is determined by
several factors, including receptor number and agonist
concentration. However, studies of G-protein-mediated
signaling in many different cell types suggest that the size
of a PLC response is also highly dependent upon whether
the PTX-sensitive or PTX-insensitive pathway is acti-
vated. Receptors that couple to PTX-insensitive G pro-
teins typically generate large increases in PIP 2 hydrolysis
and intracellular Ca2+ release, whereas receptors that sig-
nal exclusively through PTX-sensitive G proteins usually
evoke significantly smaller PLC responses [7,12,13]. In
some cases, PTX-sensitive activation of PLC signaling is
so limited that it can only be detected at high receptor
levels and with large doses of agonist. For example, m4
muscarinic acetylcholine receptors (m4 receptors), which
couple to PTX-sensitive G proteins, efficiently inhibit
adenylyl cyclase at low doses of agonist, but only weakly
stimulate PLC activity even at saturating agonist concen-
trations [11,21,22]. Thus, it is not clear whether the
stimulation of PLC activity by the m4 receptor, or other
functionally similar receptors, plays a significant role in
the generation of cellular responses.
To explore the functional significance of PLC stimulation
by the m4 receptor, we have investigated the regulation of
this pathway within the context of other signals that may
normally converge upon cells expressing this receptor
subtype. As most cells express several different types of G-
protein-coupled receptor, it is likely that mechanisms
exist that allow cells to integrate multiple agonist signals,
and thus generate second-messenger and physiological
responses that are distinct from those elicited by the indi-
vidual agonists. Previous studies have shown that acetyl-
choline and ATP are frequently co-released at various
synapses and may thus be involved in some form of signal
integration [23,24].
We therefore tested whether ATP, acting via G-protein-
coupled purinergic receptors, may influence signal trans-
duction mediated by the m4 receptor in cells expressing
both types of receptor. We found that agonist activation
of m4 receptors, expressed in Chinese hamster ovary
(CHO) cells, resulted in a small, PTX-sensitive release of
intracellular Ca2 +. Importantly, this response was greatly
enhanced when endogenous purinergic receptors, which
stimulate PLC via PTX-insensitive G proteins, were con-
currently activated with ATP. Moreover, m4-receptor-
induced transcription of the c-fos gene, which is a
Ca2 +-sensitive response, was also potentiated when
purinergic receptors were simultaneously activated.
The synergistic effect of purinergic receptors on PLC
activation did not require the influx of external Ca2+ and
occurred with little or no purinergic-receptor-stimulated
Ca2+ release. In addition, the co-activation of purinergic
receptors failed to potentiate the Ca2 + responses generated
by the m3 receptor, suggesting that the enhancement of
receptor-mediated PLC activation may require cross-talk
between PTX-sensitive and PTX-insensitive G-protein
pathways. Lastly, the results of PIP2 hydrolysis assays indi-
cate that the potent stimulation of m4-receptor-mediated
Ca2+ release by purinergic receptors resulted from a syner-
gistic increase in agonist-induced PLC activity. Our results
therefore demonstrate that the m4 receptor is a condi-
tional, but potent, activator of Ca2+ release, and suggest
that this type of receptor may act in a 'coincidence detec-
tion system' that integrates and amplifies PLC-mediated
signals originating from distinct receptors coupled to both
PTX-sensitive and PTX-insensitive G proteins.
Results
Purinergic receptors enhance m4-receptor-mediated
calcium signaling
Like several other types of receptor that couple selectively
to PTX-sensitive G proteins, the m4 receptor caused only
small increases in the [Ca2 +]i in CHO cells treated with
carbachol, a stable analog of acetylcholine (Figs la and 2a)
[12,13]. Carbachol concentrations above 10 pLM were
required to elicit a detectable Ca2 + response, and the car-
bachol concentration that gave a half-maximal response
was at least 100 .LM (Fig. 2a). In contrast to the weak
responses evoked by carbachol, the activation of endoge-
nous purinergic receptors by the application of ATP
alone resulted in large, rapid and transient increases in
[Ca2 +]i that were half maximal at agonist concentrations
of-5 RIM (Fig. lb and data not shown). The addition of
adenosine itself had no effect on [Ca2 +]i (data not shown),
and treatment of the cells with the P2 purinergic receptor
antagonist suramin eliminated the ATP-mediated Ca2+
transient (Fig. lb; [25,26]), thus demonstrating that the
potent Ca2 + responses were mediated via the activation
of G-protein-coupled purinergic receptors by ATP.
Interestingly, the m4-receptor-mediated Ca2 + response
was markedly enhanced when cells were first treated
with ATP (Fig. lb). Following ATP addition, carbachol
evoked large and transient Ca2+ increases that were
often similar in magnitude and kinetics to those evoked
by endogenous purinergic receptors. It was not essential
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Fig. 1. ATP strongly enhances the Ca2+ responses evoked by activation of the m4 receptor in CHO cells. (a) The averaged Ca2+ response of
m4-receptor-expressing CHO (CHO-m4) cells evoked by 25 RLM carbachol, as determined by ratiometric fluorescence imaging of fura-2AM-
loaded cells (six experiments, 64 cells per experiment). Absolute [Ca2+]i levels are plotted as a function of time.; the arrow marks the time of
carbachol addition. (b) A representative trace depicting the Ca2 + response in CHO-m4 cells stimulated first with 10 M ATP followed three
minutes later by the addition of 25 p.M carbachol (black line). The experiment was repeated six times with similar results. The same experiment
was performed four times each on cells pretreated with 200 pM atropine (blue line) or 200 p.M suramin (red line). (c) A dose of ATP insufficient
to elicit Ca2+ release potentiates the m4-receptor-mediated Ca2+ response. A representative trace is shown of the Ca2 + response in CHO-m4
cells evoked by the addition of 100 nM ATP followed three minutes later by the addition of 25 SpM carbachol (n = 14). (d) Agonist-induced
Ca2 + responses in CHO-m4 cells evoked by the simultaneous addition of 10 p.M carbachol and 100 nM ATP (ATP + carb, black trace) or the
sequential additional of 100 nM ATP followed three minutes later by 10 F.M carbachol (ATP--carb, red trace); the time of carbachol applica-
tion is shown by the arrowhead (n = 4). (e) Removal of ATP from the bath before carbachol addition eliminates the enhanced Ca2+ responses in
CHO-m4 cells. In this representative trace, 100 nM ATP was added to the bath and then washed out two minutes later by three complete
replacements of the bath volume (W); 10 p.M carbachol was added one minute after ATP washout (n = 7). (f) PTX eliminates the enhancement
of m4-receptor-induced Ca2 + responses, but does not block ATP-induced Ca2 + release. Average Ca2+ responses in CHO-m4 cells that were
either treated (blue line) or not treated (black line) with 100 ng ml - PTX for 12 hours before agonist addition. For both conditions, cells were
treated with 50 iM ATP followed three minutes later with 25 M carbachol. Each trace represents the averaged Ca2 + responses derived from
four experiments.
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Enhancement of the Ca2+ response without detectable
purinergic-receptor-induced Ca2+ release or influx
To discover whether the mechanism underlying the
enhancement of agonist-induced Ca2+ responses was
dependent upon a Ca2 + signal evoked by purinergic
receptors, we determined the minimal dose of ATP
required to potentiate m4-receptor-induced intracellular
Ca2 + release. Interestingly, enhancement of m4-receptor-
stimulated Ca2 + transients was not dependent upon the
magnitude of the purinergic-receptor-mediated release
of intracellular Ca2+. For example, the carbachol-stimu-
lated Ca2+ response was maximally enhanced by low
doses of ATP (100 nM) that did not result in a detectable
change in [Ca2+]i (Fig. c). Minimal activation of
purinergic receptors by 100 nM ATP increased the mag-
nitude of the peak Ca2 + transients evoked by large doses
of carbachol (1 mM), and resulted in significant responses
even at agonist concentrations (<100 nM carbachol) that
alone would fail to evoke any change in [Ca2+]i (Fig. 2a).
Fig. 2. ATP enhances the Ca2 + responses evoked by m4
receptors, but does not affect m3-receptor-mediated Ca2 +
release. Dose-response curves are shown for the peak Ca2 +
responses evoked by carbachol in CHO cells expressing either(a) the m4 receptor or (b) the m3 receptor. Cells were stimulated
with carbachol in the presence (blue) or absence (red) of 100 nM
ATP (applied 3 minutes before carbachol). Peak responses were
determined by subtracting the [Ca2+ i before carbachol addition
from the average of the maximal [Ca2+]l values recorded after
carbachol addition.
that the addition of ATP was followed by the addition
of carbachol, because potent Ca2+ signals were also
evoked when both agonists were applied simultaneously
(Fig. d; and see below). However, the enhanced res-
ponses did require the concurrent activation of both
purinergic and m4 receptors, because carbachol failed
to evoke significant Ca2 + transients when ATP was
removed from the bath before addition of the
muscarinic agonist (Fig. le). Moreover, addition of the
muscarinic and purinergic antagonists atropine and
suramin, respectively, blocked the Ca2+ response evoked
by their target receptors, as well as the enhanced Ca2+
signal resulting from the concurrent agonist activation of
both receptor types (Fig. lb). Furthermore, pretreatment
of cells with PTX abolished both the basal (carbachol
alone) and the ATP-enhanced Ca2 + responses mediated
by the m4 receptor, although the purinergic-receptor-
stimulated Ca2 + transients were not affected by the toxin
(Fig. f, and data not shown). Purinergic receptors
therefore activate a PTX-insensitive pathway that causes
a potent, but conditional, enhancement of m4 receptor-
mediated Ca2+ signaling without altering the receptor's
G-protein specificity.
The increased Ca2+ transients evoked by a wide range of
carbachol concentrations occurred in the absence of any
significant ATP-induced change in the affinity of the m4
receptor for carbachol (see Materials and methods). To
test whether ATP receptors enhanced m4-receptor-
mediated responses through a Ca2 +-influx mechanism,
the ATP-dependent potentiation of m4-receptor-
mediated Ca2 + release was measured in the absence of
extracellular Ca2+. We observed no significant difference
in the peak amplitude of the enhanced, carbachol-
induced Ca2+ transients measured in the absence of extra-
cellular Ca2+, although there was a significant reduction
in the late plateau phase of the response (Fig. 3a). Thus,
the synergistic increase in m4-receptor-stimulated Ca2+
responses by purinergic receptors does not require a
significant ATP-induced release of Ca2+ from intracellular
stores or Ca2+ influx across the plasma membrane.
Enhanced Ca2+ responses by activation of distinct G-protein
pathways
Because m4 receptors and endogenous purinergic recep-
tors evoke Ca2+ transients through PTX-sensitive and
PTX-insensitive G proteins, respectively, we investigated
whether the mechanism of agonist-enhanced Ca2+
signaling requires an interaction between these two gen-
eral classes of G proteins. In order to test whether
purinergic receptors are able to enhance the Ca2 +
responses evoked by other receptors that stimulate PLC
through PTX-insensitive G proteins, we treated CHO
cells expressing the m3 receptor with 100 nM ATP and
increasing doses of carbachol (Fig. 2b). The dose-
response curves for m3-receptor-expressing CHO cells
demonstrated that the co-activation of purinergic re-
ceptors had no effect on the magnitude or kinetics of
carbachol-mediated Ca2 + transients, even at carbachol
concentrations that evoked sub-maximal Ca 2+ responses
similar to those generated via the m4 receptor (Fig. 2a).
To investigate whether small Ca2+ transients evoked by
PTX-sensitive G proteins could potentiate subsequent
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activated by the binding of an agonist to its receptor.
Therefore, the potentiation of m4-receptor-dependent
Ca2 + signaling by purinergic receptors could be the
result of an enhancement of various steps in this pathway,
including agonist-stimulated PLC activation or IP 3-
induced release of Ca2+ from intracellular stores. To
determine whether the effect of purinergic receptors on
m4-receptor-induced Ca 2+ signaling involves an
enhancement in PLC activity, IP 3 levels were measured
following the application of muscarinic and purinergic
agonists. Stimulation of m4 receptors with 10 -tM carba-
chol resulted in a small, but consistent increase in IP 3 for-
mation, whereas activation of purinergic receptors alone
with a low dose of ATP (100 nM) had little or no effect
on PIP2 hydrolysis (Fig. 4). As in the previous Ca2 +-
release assays, sequential treatment of cells with low doses
of ATP followed by carbachol evoked a substantial
increase in PLC activity; the resulting inositol phosphate
levels were significantly larger than the sum of the
responses evoked by either agonist alone (Fig. 4).
Fig. 3. Ca2+ influx and Ca2 + release from intracellular stores are
not sufficient to enhance m4-receptor-mediated Ca2+ responses.
(a) The role of Ca2 + influx was determined by treating cells with
10 i.M carbachol in the presence (black line) or absence (red
line) of 1.8 mM extracellular Ca2+; 100 nM ATP was added to
cells three minutes before carbachol addition. Carbachol evoked
very limited increases in intracellular Ca2+ in the absence of ATP
(blue line). Each trace is the average of seven experiments. (b)
CHO-m4 cells treated with 10 p.M carbachol generate a small
increase in intracellular Ca2+ that does not enhance the subse-
quent Ca2+ response evoked by a second application of carba-
chol (1 mM final concentration). The trace is an average of three
experiments. Arrows indicate the time of carbachol addition.
PTX-sensitive Ca2+ responses, we pretreated cells with a
dose of carbachol sufficient to produce a limited Ca2 +
increase (similar to that generated by 100 nM ATP), and
tested whether this treatment was able to enhance the
response evoked by a second application of carbachol.
This analysis revealed that an initial Ca2+ signal generated
by the m4 receptor was unable to enhance subsequent
carbachol-induced Ca2 + responses (Fig. 3b). Although
the initial (10 LiM) carbachol application may have
caused some desensitization of one or more steps in the
signal transduction pathway, m4 receptors were still able
to mediate small increases in [Ca 2+]i when treated with a
second (1 mM) dose of carbachol (Fig. 3b). Thus, these
experiments suggest that the enhancement of receptor-
dependent Ca2 + signaling in these cells may require
crosstalk between PTX-sensitive and PTX-insensitive
G-protein pathways.
Synergistic enhancement of PLC activation by m4 receptors
and purinergic receptors
The release of Ca2 + from internal stores is one output
of an amplified, multi-step signaling pathway that is
Because all of the known G-protein-regulated PLC
isozymes are stimulated by Ca2+, we also investigated
whether the synergistic increase in agonist-induced PLC
activity required a Ca2 +-influx signal. In the absence of
extracellular Ca2+, co-activation of m4 receptors and
purinergic receptors still evoked a synergistic increase in
inositol phosphate formation, although the magnitude
of the enhanced PLC response was substantially
decreased (Fig. 4). This reduction in PLC activity in the
absence of extracellular Ca2+ may be responsible for the
decrease in the Ca2+ response at late plateau phase, as
seen in Figure 3a. However, these experiments suggest
that the synergistic increase in PLC activity caused by the
co-activation of m4 receptors and purinergic receptors
Fig. 4. ATP causes a synergistic enhancement of m4-receptor-
stimulated PLC activity in CHO-m4 cells. Total inositol
monophosphate was measured in CHO-m4 cells treated with
10 pM carbachol alone, 100 nM ATP alone, or 100 nM ATP
followed three minutes later with 10 pM carbachol (ATP -* carb-
achol). All cells were treated with agonist for 15 minutes before
extraction. Experiments were performed in the presence (shaded
bars, n = 4) or absence (white bars, n = 2) of 1.8 mM extra-
cellular Ca2+. Error bars represent the standard error of the mean
for each set of experiments.
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(see Materials and methods for experimental details).
Thus, these studies did not support the hypothesis that
an m4- or purinergic-receptor-regulated kinase or
phosphatase was involved in the mechanism of agonist-
enhanced Ca2 + signaling, although such proteins or
potentiating factors may exist but be unaffected by these
pharmacological agents.
Fig. 5. Coincident stimulation of CHO-m4 cells with ATP and
carbachol enhances agonist-dependent induction of the c-fos
gene. Messenger RNA was isolated from cells that were
untreated (lane 1) or treated with 100 nM ATP (lane 2), 10 FxM
carbachol (lane 3) or both agonists (lane 4). After 8 minutes the
agonists were washed out, fresh media containing the muscarinic
antagonist atropine (100 IzM) was added, and cells were incu-
bated for a further 15 minutes. Cells were maintained at 37°C
throughout the experiment. A nitrocellulose filter containing
approximately 2 g of mRNA per lane was hybridized with a
CHO-derived c-fos probe (top panel). The relative amount of
mRNA present in each lane was determined by probing the same
filter with a CHO-derived probe for glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA (bottom panel). Similar results
were obtained in four independent experiments.
may be sufficient to account for the strong enhancement
of the Ca2+ responses evoked by ATP and carbachol.
Because the enhancement of m4-receptor-mediated
Ca2 + signaling by purinergic receptors occurred when
ATP and carbachol were applied either sequentially or
simultaneously, this process may depend on a rapid
change in the phosphorylation state of a component
within the PLC signaling cascade, or the production of
a short-lived potentiating factor [27]. To test the possi-
bility that PKC activity is involved in the enhancement
of Ca2+ responses, cells were treated with the PKC acti-
vator phorbol myristate acid (PMA,) or the PKC
inhibitor staurosporine, prior to ATP and carbachol addi-
tion; neither treatment altered the ability of ATP to
enhance carbachol-induced Ca2+ transients. Similarly,
addition of the serine/threonine-phosphatase inhibitors
okadaic acid and calyculin, or the tyrosine-phosphatase
inhibitor vanadate, did not alter the enhanced Ca2 +
responses or prevent the loss of potentiation resulting
from the washout of ATP prior to carbachol application
Enhanced c-fos transcription by co-activation of m4
receptors and purinergic receptors
To investigate whether the enhancement of m4-receptor-
mediated PLC activation is translated into an increased
cellular response, we tested the effects of carbachol and
ATP on induction of the c-fos immediate early gene.
Previous studies have shown that neurotransmitters and
pharmacological agents that elevate [Ca2 +]i can stimulate
transcription of the c-fos gene through a promoter
sequence termed the Ca2 +-response element [28]. To
measure receptor-stimulated c-fos transcription, mRNA
was isolated from serum-starved CHO cells, following
brief incubations with ATP, carbachol or both agonists,
and analyzed by filter hybridization with a c-fos probe.
Treatment with a low dose of ATP (100 nM), insufficient
to evoke an increase in PLC activity or intracellular Ca2+
release, also failed to induce transcription of the c-fos
gene (Fig. 5). Incubation with 10 p.M carbachol induced
a significant increase in c-fos mRNA levels; however, this
response was enhanced more than two-fold when cells
were treated with minimal doses of both ATP and carba-
chol (Fig. 5). Thus, these results demonstrate that the
increased magnitude of PLC-dependent signals evoked
by co-activation of the m4 and purinergic receptors
results in a substantial enhancement of at least one down-
stream cellular response - the transcriptional induction
of an immediate early gene.
Discussion
Previous studies have not clearly shown whether the
ability of the m4 receptor weakly to stimulate PLC activ-
ity and intracellular Ca2+ release plays a significant role in
the signal transduction pathways regulated by this type of
G-protein-coupled receptor. The results presented here
demonstrate that the m4 receptor is a conditional, but
strong, activator of Ca2+ signaling, and reveal a poten-
tially important role for this receptor in the integration of
concurrent agonist signals. We found that the magnitude
of the Ca2+ response evoked by the m4 receptor was dra-
matically increased when purinergic receptors were
simultaneously treated with ATP. Moreover, the activa-
tion of purinergic receptors significantly enhanced the
sensitivity of the cell to m4-receptor-mediated PLC acti-
vation over a wide range of carbachol concentrations
without causing any significant change in the affinity of
the m4 receptor for carbachol. Thus, when purinergic
receptors were co-activated, substantial Ca2+ release was
evoked by low doses of carbachol (10-100 nM) that
otherwise exclusively couple the m4 receptor to adenylyl
cyclase inhibition [11].
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In addition to potentiating the Ca2 + response evoked by
the m4 receptor, we found that co-activation of purinergic
receptors also enhanced carbachol-induced transcription
of the c-fos immediate early gene, an important output of
Ca2+ signaling in many cell types [28]. As acetylcholine
and ATP are often co-released during synaptic trans-
mission, it is possible that a similar enhancement of
second-messenger-dependent responses occurs when m4
receptors and purinergic receptors are simultaneously
activated in vivo. Thus, these studies strongly suggest that
PLC is a significant downstream effector of the m4
receptor, and further demonstrate the importance of
examining the functional properties of a given receptor
within the context of other signaling pathways that may
be simultaneously active within the same host cell.
PIP 2 hydrolysis assays indicate that the enhancement of
m4-receptor-dependent Ca2+ release by purinergic recep-
tors can be attributed to a synergistic increase in agonist-
induced PLC activity. Because m4 receptors and
purinergic receptors signal through PTX-sensitive and
PTX-insensitive G proteins, respectively, it is likely that
these receptors activate distinct PLC isozymes. Previous
investigations have shown that several PLC isozymes can
be activated by both G, and Gy subunits. However, in
vitro studies suggest that G subunits released from
PTX-sensitive G proteins may preferentially activate the
32 and 33 isozymes of PLC, whereas PTX-insensitive
Ga, subunits of the Ga/ / class may preferentially stimu-
late PLC31 [17-19] (the presence of each of these PLC
isozymes in the CHO cells used in this study has been
confirmed by immunoblot analysis; R.C.C., unpublished
observations). Thus, the enhanced Ca2 + responses
described here represent a form of crosstalk between the
two principal G-protein pathways leading to PLC stimu-
lation in this cell type. Furthermore, the ability of PTX
to block the enhancement of m4-receptor-evoked Ca2 +
transients, and the failure of purinergic receptors to
enhance the Ca2 + responses generated by m3 receptors,
both suggest that agonist-dependent potentiation of PLC
signaling may actually require the activation of both
PTX-sensitive and PTX-insensitive G-protein pathways.
The G-protein pathways involved in the cooperative
enhancement of Ca2+ signaling appear to converge at or
before the level of PLC activation. It is possible that the
biochemical mechanism underlying the enhanced
responses involves a purinergic-receptor-induced increase
in the efficiency, or intrinsic rate, with which the m4
receptor activates its substrate G proteins. As PTX-
sensitive PLC activation and adenylyl cyclase inhibition
appear to be mediated by the same G proteins in CHO
cells [29], such a mechanism should enhance the ability
of the receptor to regulate both effectors. However, the
inhibition of adenylyl cyclase by the m4 receptor is unaf-
fected by purinergic receptor signaling in these cells
(R.C.C., unpublished observations).
An alternative mechanism for the cooperative enhance-
ment of Ca2 + signaling is that the co-activation of
purinergic and m4 receptors results in the release of an
intermediate signaling molecule that triggers the
enhancement of PLC-dependent responses. The ability
of Ca2 + to stimulate PLC activity and evoke further Ca2 +
release makes it a likely candidate for such a potentiating
molecule [1,27]; for example, the minimal stimulation of
PLC activity evoked by purinergic receptors may cause a
transient increase in [Ca2 +]i, sufficient to potentiate the
PLC responses resulting from the concurrent activation
of m4 receptors. However, if purinergic-receptor-
induced Ca2+ release or IP3 formation is responsible for
the enhanced m4-receptor responses, then the required
concentrations of these second messengers are too low to
be detected by our assays. Furthermore, if transient
increases in intracellular Ca2 + are sufficient to enhance
receptor-stimulated PLC activity in these cells, it is
unclear why the small Ca2+ responses evoked by inter-
mediate doses of carbachol do not allow the m4 receptor
to enhance its own Ca2+ signals through a positive-
feedback mechanism. Similarly, the Ca2 + transients
evoked by purinergic receptors failed to enhance the
submaximal, PTX-insensitive Ca2+ responses generated
by m3 receptors at low carbachol concentrations.
Our experiments did not, therefore, reveal a requirement
for Ca2+ in the mechanism underlying agonist-induced
enhancement of PLC activity in CHO cells, although
minimal or extremely brief and highly localized increases
in [Ca2+]i could be involved in this process. Some
potentiating factor other than Ca2 + may contribute to
the enhanced responses that we have described. How-
ever, the apparent requirement for the activation of both
PTX-sensitive and PTX-insensitive G proteins suggests
that the underlying mechanism involves one or more
intrinsic differences between the two pathways linking
m4 and purinergic receptors to the enhancement of PLC
activity in these cells.
Previous attempts to understand the mechanisms by which
cells interpret independent, but convergent, signal
transduction pathways have led to the identification of
certain proteins, termed coincidence detectors, that play
key roles in the integration of temporally coincident input
signals [30]. When two distinct signals are simultaneously
received, coincidence detectors allow the cell to generate
output signals that differ substantially from those generated
by either input alone. Examples of coincidence detectors
include type I adenylyl cyclase, the catalytic activity of
which is synergistically enhanced through the binding of
Ca2 +-calmodulin and GTP-bound Gs, and the NMDA
subtype of glutamate receptor, the channel activity of
which is dependent upon glutamate and glycine binding,
as well as membrane depolarization [30]. The potent
enhancement of m4-receptor-induced Ca2 + signaling
evoked by the concurrent activation of purinergic recep-
tors suggests that the signaling pathways regulated by these
distinct receptor types may contain a coincidence detector.
Dose-response experiments revealed that purinergic recep-
tors fully enhanced m4-receptor-dependent Ca2 + signals
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over a wide range of ATP concentrations, including min-
imal doses that failed to induce a Ca 2+ transient on their
own; however, enhancement of Ca2+ responses was only
observed when carbachol and ATP were present at the
same time. Moreover, the co-activation of m4 and
purinergic receptors evoked increases in PIP 2 hydrolysis
and intracellular Ca2+ release that were dramatically greater
than the sum of responses elicited by either carbachol or
ATP treatment alone. Thus, coincidence detection at the
level of PLC activity offers the cell a way of integrating and
transforming the temporal component of neurotransmitter
reception into the magnitude of subsequent Ca2+ transients
and other downstream PLC-dependent responses.
Our results suggest that the coincidence detector within
this system may be a PLC isozyme, perhaps PLC32
or PLC,3. The activity of this PLC isozyme may be
regulated by a primary signal generated by the m4 recep-
tor - GPy subunits, perhaps - and modified by a
secondary input provided by purinergic receptors. The sec-
ondary input could be a product of PLC metabolism gen-
erated by the PTX-insensitive pathway, or a downstream
kinase or phosphatase. Alternatively, a secondary input may
be provided directly by the Ga subunits that are released as
a consequence of purinergic receptor activation. These
PTX-insensitive Ga subunits may further stimulate PLC
enzymes that are activated by Gy subunits derived from
the m4 receptor pathway, in a manner somewhat analogous
to Gas- and Gi3-dependent activation of type II adenylyl
cyclase [31]. It is also possible that signals generated by the
m4 receptor enhance the activity of the PLC isozyme,
perhaps PLC,1, that lies within the purinergic receptor
pathway. However, as even moderate doses of ATP alone
are sufficient to evoke maximal Ca 2+ responses in these
cells, this presumptive G q-regulated PLC isozyme may be
more limited in its putative role as a coincidence detector.
The synergistic enhancement of carbachol-induced PLC
signaling by purinergic receptors provides a novel insight
into the general nature of signal transduction via the m4
receptor and other, functionally similar, G protein-coupled
receptors. Although activation of Gcai proteins by the m4
receptor probably plays some role in reducing the basal
level of cAMP within the cell, potent m4 receptor-
mediated inhibition of adenylyl cyclase is most readily
observed when the enzyme is concurrently activated by
receptors that couple to the stimulatory Gas protein [32].
Similarly, robust activation of Ca2 + responses by the m4
receptor is only evident when a weak, but coincident
potentiating signal is provided via a distinct PLC-activating
receptor. Thus, various G-protein-coupled receptor fami-
lies may include subtypes, such as the m4 receptor, that fre-
quently act as modulators of the signals produced by other
receptors, rather than as transducers of independent signals.
Conclusions
Our results demonstrate that the m4 receptor is a potent,
but conditional, activator of Ca2+ signaling when a
distinct type of G-protein-coupled receptor is simulta-
neously active. The enhanced PLC-dependent responses
reported here require concurrent activation of m4 recep-
tors and P2 purinergic receptors, and are of greater mag-
nitude that the sum of the responses evoked by either
receptor alone. Thus, the m4 receptor may participate in a
coincidence-detection system that amplifies simultaneous
PLC-activating signals generated by PTX-sensitive and
PTX-insensitive G-protein pathways. Because cells may
normally receive multiple hormonal and neurotransmitter
signals in vivo, these findings suggest one mechanism by
which the temporal information encoded in these signals
can be integrated into distinct PLC-dependent responses.
Materials and methods
Materials
PTX was purchased from List Biochemical. ATP was obtained
from Pharmacia. Fura-2AM and Plurionic F127 were
purchased from Molecular Probes. All cell-culture materials
were obtained from Gibco/BRL. Okadaic acid was kindly
provided by T. Hastett. RNazol (Tel-Test) and a
PolyATtractIII kit (Promega) were used for mRNA isolation.
All other chemicals were purchased from Sigma.
Cell culture
CHO cells were transfected with a plasmid containing a cDNA
encoding the m4 receptor under the transcriptional control of
the simian virus 40 early promoter, as previously described
[7,33]. Stable transfections were selected and amplified in 50 nM
methotrexate; similar results were obtained with several inde-
pendent cell lines expressing the m4 receptor (CHO-m4 cells).
CHO cells expressing the m3 receptor (CHO-m3 cells) were
constructed as described previously [14]. The transfected CHO
cells expressed -1.6 x 105 and 4 x 105 receptors per cell, respec-
tively, as determined by Scatchard analysis [11]. The specific
activity of the receptors was 48 pmol mg-1 and 9 pmol mg- 1
for the m3-expressing and m4-expressing CHO cell lines,
respectively. To determine whether activation of purinergic
receptors with 100 nM ATP altered the affinity of the m4
receptor for carbachol, competition-displacement experiments
were conducted with [3 H]-N-methyl scopolamine and various
doses of carbachol, using CHO-m4 cells that were either
treated or not treated with 100 nM ATP. Triplicate determina-
tions revealed that the m4 receptor displayed asingle-affinity
state, with a Kd for carbachol of 16.4 ± 2.8 p.M in the presence
of 100 nM ATP, and 9.2 ± 2 p.M in the absence of ATP.
Calcium imaging and cell treatment
CHO cells were trypsinized and plated on glass coverslips 48 h
before each experiment. For PTX pretreatment, cells were
transferred to media containing 100 ng ml- of toxin and
incubated for 12 h at 37 °C in 5 % CO2. Intracellular Ca2+
concentrations were determined by ratiometric analysis as
previously described [14,29,34]. Ca 2+ responses were averaged
from 64 cells per experiment.
Agonists were added to the bath manually, with rapid mixing.
In experiments using okadaic acid (1 jiM), calyculin (10 IM),
vanadate (100 M) and staurosporine (1 RiM), the drugs were
added 10 min before addition of ATP while the cells were
maintained at 37 °C. In experiments using staurosporine,
100 nM ATP was added to the cells, followed by carbachol
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(10 I.M) addition 3 min later. Similar experiments were per-
formed with the phosphatase inhibitors, except that cells were
incubated with ATP for 2 min, extensively washed by three full
changes of the bath saline containing the phosphatase inhibitor
and lacking ATP, followed by the addition of carbachol. To
test the effects of phorbol esters, PMA (100 nM) was added to
the cells 5 min before the addition of 10 JIM carbachol.
Measurement of PIP2 hydrolysis
Agonist-stimulated PIP2 hydrolysis was assayed in 6-well plates
containing adherent CHO cells, previously labeled with
[3 H]myo-inositol, by measuring the accumulation of inositol
monophosphate using anion-exchange chromatography
[7,11,35]. Inositol monophosphatase activity was inhibited by
the inclusion of 10 mM LiCl during the assay. In the absence
of agonists, basal inositol monophosphate levels in CHO-m4
cells increased by 50 + 40 c.p.m. per x 106 cells during the
15 minute incubation.
Northern analysis
Cells were grown to near confluence on 150 mm plates,
serum-starved for 36 h and maintained at 37°C for the dura-
tion of each experiment. Cells were placed on ice and rapidly
solubilized by the addition of 10 ml RNazol; total RNA was
prepared as suggested by the manufacturer (Tel-Test).
Polyadenylated mRNA was isolated using a Promega PolyAT-
tract III kit. Approximately 2 jig mRNA per sample was sepa-
rated on an agarose-formaldehyde gel and transferred to a
nitrocellulose filter. The filter was probed with a uniformly
3 2 P-labeled, 400 base-pair fragment containing a portion of the
coding region of the CHO c-fos gene under moderate strin-
gency (30 % formamide), as described [33]. Levels of mRNA
were compared by re-probing the same filter with a uniformly
3 2 P-labeled, 250 base-pair fragment containing a portion of the
coding region of a CHO-derived glyceraldehyde 3-phosphate
dehydrogenase gene.
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